Report Detail
Global (United States, European Union and China) Parkinson’s Disease Drugs Market Research Report 2019-2025
- RnM3636405 |
- 30 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors.
In 2019, the market size of Parkinson’s Disease Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Parkinson’s Disease Drugs.
This report studies the global market size of Parkinson’s Disease Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Parkinson’s Disease Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
F. Hoffmann-La Roche
AbbVie
Teva Pharmaceutical Industries
UCB Inc.
STADA Arzneimittel
GlaxoSmithKline
Valeant Pharmaceuticals International
Merck
Impax Laboratories
Market Segment by Product Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Parkinson’s Disease Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Parkinson’s Disease Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Parkinson’s Disease Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Parkinson’s Disease Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral
- 1.3.3 Transdermal
- 1.3.4 Subcutaneous
- 1.3.5 Intestinal Infusion
- 1.4 Market Segment by Application
- 1.4.1 Global Parkinson’s Disease Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Parkinson’s Disease Drugs Market Size
- 2.1.1 Global Parkinson’s Disease Drugs Revenue 2014-2025
- 2.1.2 Global Parkinson’s Disease Drugs Sales 2014-2025
- 2.2 Parkinson’s Disease Drugs Growth Rate by Regions
- 2.2.1 Global Parkinson’s Disease Drugs Sales by Regions 2014-2019
- 2.2.2 Global Parkinson’s Disease Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Parkinson’s Disease Drugs Sales by Manufacturers
- 3.1.1 Parkinson’s Disease Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Parkinson’s Disease Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Parkinson’s Disease Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Parkinson’s Disease Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Parkinson’s Disease Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Parkinson’s Disease Drugs Price by Manufacturers
- 3.4 Key Manufacturers Parkinson’s Disease Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Parkinson’s Disease Drugs Market
- 3.6 Key Manufacturers Parkinson’s Disease Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Oral Sales and Revenue (2014-2019)
- 4.1.2 Transdermal Sales and Revenue (2014-2019)
- 4.1.3 Subcutaneous Sales and Revenue (2014-2019)
- 4.1.4 Intestinal Infusion Sales and Revenue (2014-2019)
- 4.2 Global Parkinson’s Disease Drugs Sales Market Share by Type
- 4.3 Global Parkinson’s Disease Drugs Revenue Market Share by Type
- 4.4 Parkinson’s Disease Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Parkinson’s Disease Drugs Sales by Application
6 United States
- 6.1 United States Parkinson’s Disease Drugs Breakdown Data by Company
- 6.2 United States Parkinson’s Disease Drugs Breakdown Data by Type
- 6.3 United States Parkinson’s Disease Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Parkinson’s Disease Drugs Breakdown Data by Company
- 7.2 European Union Parkinson’s Disease Drugs Breakdown Data by Type
- 7.3 European Union Parkinson’s Disease Drugs Breakdown Data by Application
8 China
- 8.1 China Parkinson’s Disease Drugs Breakdown Data by Company
- 8.2 China Parkinson’s Disease Drugs Breakdown Data by Type
- 8.3 China Parkinson’s Disease Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Parkinson’s Disease Drugs Breakdown Data by Company
- 9.2 Rest of World Parkinson’s Disease Drugs Breakdown Data by Type
- 9.3 Rest of World Parkinson’s Disease Drugs Breakdown Data by Application
- 9.4 Rest of World Parkinson’s Disease Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Parkinson’s Disease Drugs Sales by Countries
- 9.4.2 Rest of World Parkinson’s Disease Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.1.4 Parkinson’s Disease Drugs Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 F. Hoffmann-La Roche
- 10.2.1 F. Hoffmann-La Roche Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.2.4 Parkinson’s Disease Drugs Product Introduction
- 10.2.5 F. Hoffmann-La Roche Recent Development
- 10.3 AbbVie
- 10.3.1 AbbVie Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.3.4 Parkinson’s Disease Drugs Product Introduction
- 10.3.5 AbbVie Recent Development
- 10.4 Teva Pharmaceutical Industries
- 10.4.1 Teva Pharmaceutical Industries Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.4.4 Parkinson’s Disease Drugs Product Introduction
- 10.4.5 Teva Pharmaceutical Industries Recent Development
- 10.5 UCB Inc.
- 10.5.1 UCB Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.5.4 Parkinson’s Disease Drugs Product Introduction
- 10.5.5 UCB Inc. Recent Development
- 10.6 STADA Arzneimittel
- 10.6.1 STADA Arzneimittel Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.6.4 Parkinson’s Disease Drugs Product Introduction
- 10.6.5 STADA Arzneimittel Recent Development
- 10.7 GlaxoSmithKline
- 10.7.1 GlaxoSmithKline Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.7.4 Parkinson’s Disease Drugs Product Introduction
- 10.7.5 GlaxoSmithKline Recent Development
- 10.8 Valeant Pharmaceuticals International
- 10.8.1 Valeant Pharmaceuticals International Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.8.4 Parkinson’s Disease Drugs Product Introduction
- 10.8.5 Valeant Pharmaceuticals International Recent Development
- 10.9 Merck
- 10.9.1 Merck Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.9.4 Parkinson’s Disease Drugs Product Introduction
- 10.9.5 Merck Recent Development
- 10.10 Impax Laboratories
- 10.10.1 Impax Laboratories Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Parkinson’s Disease Drugs
- 10.10.4 Parkinson’s Disease Drugs Product Introduction
- 10.10.5 Impax Laboratories Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Parkinson’s Disease Drugs Sales Channels
- 11.2.2 Parkinson’s Disease Drugs Distributors
- 11.3 Parkinson’s Disease Drugs Customers
12 Market Forecast
- 12.1 Global Parkinson’s Disease Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Parkinson’s Disease Drugs Sales Forecast by Type
- 12.3 Global Parkinson’s Disease Drugs Sales Forecast by Application
- 12.4 Parkinson’s Disease Drugs Forecast by Regions
- 12.4.1 Global Parkinson’s Disease Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Parkinson’s Disease Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Parkinson’s Disease Drugs. Industry analysis & Market Report on Parkinson’s Disease Drugs is a syndicated market report, published as Global (United States, European Union and China) Parkinson’s Disease Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Parkinson’s Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
